 | EXECUTIVE OFFICE OF THE PRESIDENT
OFFICE OF MANAGEMENT AND BUDGET
WASHINGTON, D.C. 20503
| STATEMENT OF ADMINISTRATION POLICY
(THIS STATEMENT HAS BEEN COORDINATED BY OMB
WITH THE CONCERNED AGENCIES.)
April 28, 1998
(House)
|
H.R. 3717 - Prohibition Regarding Illegal Drugs and the
Distribution of Hypodermic Needles
(Rep. Solomon (R) NY and four cosponsors)
| |
The Administration strongly opposes H.R. 3717 because it is unnecessary and
unwarranted. The Administration concurs in the longstanding position of
the Congress that the Secretary of Health and Human Services should have
the authority to determine the scientific and public health merit of needle
exchange programs as they affect rates of HIV transmission and injection
drug use. The Administration believes, as Congress has to this point, that
the top public health leadership of the Federal government remains the
appropriate place for this determination, and that the decision on which
HIV prevention strategies to use should rest with State and local
officials.
|
The Budget | Legislative Information | Management Reform/GPRA | Grants Management
Financial Management | Procurement Policy | Information & Regulatory Policy
Contact the White House Web Master
Privacy Statement |
